Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A11447 | 30891575 | Animal Model Exp Med | Obese zebrafish: A small fish for a major human health condition. | 2018 | Details |
| A11448 | 30890750 | Sci Rep | Association between Helicobacter pylori infection and non-alcoholic fatty liver disease in North Chinese: a cross-sectional study. | 2019 | Details |
| A11449 | 30889997 | Expert Opin Ther Pat | A patent update on cannabinoid receptor 1 antagonists (2015-2018). | 2019 | Details |
| A11450 | 30889791 | Medicines (Basel) | The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11451 | 30889343 | Rev Med Inst Mex Seguro Soc | Nonalcoholic hepatic steatosis: a silent disease | 2019 | Details |
| A11452 | 30889136 | J Pediatr Gastroenterol Nutr | Magnetic Resonance Imaging: A Personalized Approach to Understanding Fatty Liver Disease. | 2019 | Details |
| A11453 | 30888972 | Eur J Gastroenterol Hepatol | Neutrophil-to-lymphocyte ratio is independently associated with inflammatory activity and fibrosis grade in nonalcoholic fatty liver disease. | 2019 | Details |
| A11454 | 30888971 | Eur J Gastroenterol Hepatol | Associations between sarcopenia and nonalcoholic fatty liver disease and advanced fibrosis in the USA. | 2019 | Details |
| A11456 | 30888594 | Adv Ther | Pharmacological Treatment for Non-alcoholic Fatty Liver Disease. | 2019 | Details |
| A11457 | 30888440 | Intensive Care Med | Obesity in the critically ill: a narrative review. | 2019 | Details |
| A11460 | 30887902 | Int J Vitam Nutr Res | Association of Pro-inflammatory Dietary Intake and Non-Alcoholic Fatty Liver Disease: Findings from Iranian case-control study. | 2019 | Details |
| A11461 | 30887659 | Int J Exp Pathol | Vitronectin deficiency attenuates hepatic fibrosis in a non-alcoholic steatohepatitis-induced mouse model. | 2019 | Details |
| A11462 | 30887196 | Eur Radiol | Prediction of nonalcoholic fatty liver disease (NAFLD) activity score (NAS) with multiparametric hepatic magnetic resonance imaging and elastography. | 2019 | Details |
| A11463 | 30885145 | BMC Gastroenterol | The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose. | 2019 | Details |
| A11464 | 30884843 | Cells | Ursodeoxycholic Acid Regulates Hepatic Energy Homeostasis and White Adipose Tissue Macrophages Polarization in Leptin-Deficiency Obese Mice. | 2019 | Details |
| A11467 | 30883738 | J Physiol | Challenging metabolic tissues with fructose: tissue-specific and sex-specific responses. | 2019 | Details |
| A11468 | 30882933 | Aliment Pharmacol Ther | Collagen proportionate area is an independent predictor of long-term outcome in patients with non-alcoholic fatty liver disease. | 2019 | Details |
| A11469 | 30882706 | Medicine (Baltimore) | Nonalcoholic fatty liver disease represents a greater metabolic burden in patients with atherosclerosis: A cross-sectional study. | 2019 | Details |
| A11470 | 30882489 | AIDS | Monocyte-macrophage activation is associated with nonalcoholic fatty liver disease and liver fibrosis in HIV monoinfection independently of the gut microbiome and bacterial translocation. | 2019 | Details |
| A11471 | 30882339 | Rev Fac Cien Med Univ Nac Cordoba | Effectiveness of two physical activity programs on non-alcoholic fatty liver disease. a randomized controlled clinical trial. | 2019 | Details |
| A11473 | 30881473 | Evid Based Complement Alternat Med | Jwa Kum Whan Attenuates Nonalcoholic Fatty Liver Disease by Modulating Glucose Metabolism and the Insulin Signaling Pathway. | 2019 | Details |
| A11474 | 30881345 | Front Endocrinol (Lausanne) | Endocrine Disrupting Chemicals: An Occult Mediator of Metabolic Disease. | 2019 | Details |
| A11475 | 30881075 | Diabetes Metab Syndr Obes | Dietary patterns in relation to hepatic fibrosis among patients with nonalcoholic fatty liver disease. | 2019 | Details |
| A11476 | 30879942 | J Clin Lipidol | Extremely low levels of low-density lipoprotein potentially suggestive of familial hypobetalipoproteinemia: A separate phenotype of NAFLD? | 2019 | Details |
| A11477 | 30879920 | EBioMedicine | Arid1a regulates insulin sensitivity and lipid metabolism. | 2019 | Details |
| A11478 | 30879098 | Eur J Nutr | Moderate consumption of fermented alcoholic beverages diminishes diet-induced non-alcoholic fatty liver disease through mechanisms involving hepatic adiponectin signaling in mice. | 2019 | Details |
| A11479 | 30878840 | Atherosclerosis | Ideal cardiovascular health associated with fatty liver: Results from a multi-ethnic survey. | 2018 | Details |
| A11480 | 30878016 | J Endocrinol | Short-term strength training reduces gluconeogenesis and NAFLD in obese mice. | 2019 | Details |
| A11481 | 30877708 | Diabetes Metab J | Association between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus. | 2019 | Details |
| A11482 | 30877459 | Eur Radiol | Diagnostic accuracy of hepatic proton density fat fraction measured by magnetic resonance imaging for the evaluation of liver steatosis with histology as reference standard: a meta-analysis. | 2019 | Details |
| A11483 | 30877020 | Pharmacol Ther | Intestinal microbiome as a novel therapeutic target for local and systemic inflammation. | 2019 | Details |
| A11484 | 30876963 | Clin Gastroenterol Hepatol | Crohn's Disease Is Associated With an Increased Prevalence of Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study Using Magnetic Resonance Proton Density Fat Fraction Mapping. | 2019 | Details |
| A11485 | 30876959 | Clin Gastroenterol Hepatol | Optimizing Use of Nonalcoholic Fatty Liver Disease Fibrosis Score, Fibrosis-4 Score, and Liver Stiffness Measurement to Identify Patients With Advanced Fibrosis. | 2019 | Details |
| A11486 | 30876789 | J Formos Med Assoc | The correlation between fatty liver disease and chronic kidney disease. | 2019 | Details |
| A11487 | 30875804 | Int J Mol Sci | TM6SF2 and MBOAT7 Gene Variants in Liver Fibrosis and Cirrhosis. | 2019 | Details |
| A11488 | 30875495 | Atherosclerosis | Statins and nonalcoholic fatty liver disease in the era of precision medicine: More friends than foes. | 2019 | Details |
| A11489 | 30875494 | Atherosclerosis | Non-alcoholic fatty liver disease presence and severity are associated with aortic stiffness beyond abdominal obesity: The ELSA-Brasil. | 2019 | Details |
| A11490 | 30875479 | Expert Rev Gastroenterol Hepatol | Pediatric NAFLD: an overview and recent developments in diagnostics and treatment. | 2019 | Details |
| A11491 | 30874372 | J Med Imaging Radiat Oncol | Incidental hepatic steatosis on unenhanced computed tomography performed for suspected renal colic: Gaps in reporting and documentation. | 2019 | Details |
| A11492 | 30872135 | Arab J Gastroenterol | Relationship between lifestyle factors and nutritional status and non-alcoholic fatty liver disease among a group of adult Jordanians. | 2019 | Details |
| A11493 | 30871980 | J Hepatol | Global liver disease burdens and research trends: Analysis from a Chinese perspective. | 2019 | Details |
| A11494 | 30871514 | BMC Complement Altern Med | Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial. | 2019 | Details |
| A11495 | 30871397 | J Int Med Res | Pathogenesis of and major animal models used for nonalcoholic fatty liver disease. | 2019 | Details |
| A11496 | 30871368 | Exp Biol Med (Maywood) | Nonalcoholic fatty liver disease and the gut microbiome: Are bacteria responsible for fatty liver? | 2019 | Details |
| A11497 | 30871035 | Nutrients | Eicosapentaenoic Acid Improves Hepatic Metabolism and Reduces Inflammation Independent of Obesity in High-Fat-Fed Mice and in HepG2 Cells. | 2019 | Details |
| A11498 | 30870854 | Ann Nutr Metab | Circulating Iron Levels Interaction with Central Obesity on the Risk of Nonalcoholic Fatty Liver Disease: A Case-Control Study in Southeast China. | 2019 | Details |
| A11499 | 30870804 | Nutrition | Cancer-related gene expression is associated with disease severity and modifiable lifestyle factors in non-alcoholic fatty liver disease. | 2018 | Details |
| A11500 | 30870486 | PLoS One | Fecal and blood microbiota profiles and presence of nonalcoholic fatty liver disease in obese versus lean subjects. | 2019 | Details |
| A11501 | 30868786 | J Ayub Med Coll Abbottabad | Association Of Non-Alcoholic Fatty Liver Disease With Serum Uric Acid. | 2019 | Details |
| A11504 | 30868489 | Curr Med Sci | Berberine Ameliorates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Rats via Activation of SIRT3/AMPK/ACC Pathway. | 2019 | Details |
| A11505 | 30868315 | Acta Diabetol | Oral glucose effectiveness and metabolic risk in obese children and adolescents. | 2019 | Details |
| A11506 | 30867987 | PeerJ | Comparison of laboratory indices of non-alcoholic fatty liver disease for the detection of incipient kidney dysfunction. | 2019 | Details |
| A11507 | 30867696 | Exp Ther Med | Berberine attenuates hepatic oxidative stress in rats with non-alcoholic fatty liver disease via the Nrf2/ARE signalling pathway. | 2019 | Details |
| A11508 | 30867627 | Fed Pract | Population Management of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11509 | 30867626 | Fed Pract | Comorbidities and Nonalcoholic Fatty Liver Disease: The Chicken, the Egg, or Both? | 2019 | Details |
| A11511 | 30865013 | Am J Gastroenterol | Physical Activity, Fatty Liver, and Glucose Metabolism Over the Life Course: The Lifelines Cohort. | 2019 | Details |
| A11512 | 30864855 | J Med Food | Fermented Cordyceps militaris Extract Ameliorates Hepatosteatosis via Activation of Fatty Acid Oxidation. | 2019 | Details |
| A11513 | 30864239 | J Gastroenterol Hepatol | Serum C16:1n7/C16:0 ratio as a diagnostic marker for non-alcoholic steatohepatitis. | 2019 | Details |
| A11514 | 30863439 | Gastroenterol Res Pract | Noninvasive Evaluation of Liver Function in Morbidly Obese Patients. | 2019 | Details |
| A11515 | 30862999 | World J Gastroenterol | Comprehensive lifestyle intervention vs soy protein-based meal regimen in non-alcoholic steatohepatitis. | 2019 | Details |
| A11516 | 30862046 | Int J Mol Sci | Metabolomics Characterizes the Effects and Mechanisms of Quercetin in Nonalcoholic Fatty Liver Disease Development. | 2019 | Details |
| A11517 | 30862016 | Nutrients | Nutritional Intake and the Risk for Non-Alcoholic Fatty Liver Disease (NAFLD). | 2019 | Details |
| A11518 | 30861601 | J Cell Biochem | Mitigative effects of the bioactive flavonol fisetin on high-fat/high-sucrose induced nonalcoholic fatty liver disease in rats. | 2019 | Details |
| A11519 | 30861321 | Liver Transpl | NASH Is the Most Rapidly Growing Etiology for Acute-on-Chronic Liver Failure-Related Hospitalization and Disease Burden in the United States: A Population-Based Study. | 2019 | Details |
| A11520 | 30861258 | Hepatol Res | Inhibition of microRNA-124a attenuates non-alcoholic fatty liver disease through upregulation of adipose triglyceride lipase and the effect of liraglutide intervention. | 2019 | Details |
| A11521 | 30860882 | Am J Physiol Endocrinol Metab | Transgenerational impact of maternal obesogenic diet on offspring bile acid homeostasis and nonalcoholic fatty liver disease. | 2019 | Details |
| A11522 | 30860877 | Am J Physiol Endocrinol Metab | Human Paneth cell α-defensin-5 treatment reverses dyslipidemia and improves glucoregulatory capacity in diet-induced obese mice. | 2019 | Details |
| A11523 | 30860608 | Lipids | Six-Week High-Fat Diet Alters the Gut Microbiome and Promotes Cecal Inflammation, Endotoxin Production, and Simple Steatosis without Obesity in Male Rats. | 2019 | Details |
| A11524 | 30859582 | Hepatology | Collagen Formation Assessed by N-Terminal Propeptide of Type 3 Procollagen Is a Heritable Trait and Is Associated With Liver Fibrosis Assessed by Magnetic Resonance Elastography. | 2019 | Details |
| A11525 | 30858480 | Sci Rep | Independent and combined effects of dietary iron composition and selected risk factors on the risk of NAFLD in a Chinese population. | 2019 | Details |
| A11526 | 30857678 | Food Chem | Quinoa intake reduces plasma and liver cholesterol, lessens obesity-associated inflammation, and helps to prevent hepatic steatosis in obese db/db mouse. | 2019 | Details |
| A11527 | 30856537 | Biomed Pharmacother | Ferulic acid ameliorates nonalcoholic fatty liver disease and modulates the gut microbiota composition in high-fat diet fed ApoE-/- mice. | 2019 | Details |
| A11528 | 30856468 | J Nutr Biochem | Tissue-dependent effects of cis-9,trans-11- and trans-10,cis-12-CLA isomers on glucose and lipid metabolism in adult male mice. | 2019 | Details |
| A11529 | 30855277 | J Clin Invest | Resolving inflammation in nonalcoholic steatohepatitis. | 2019 | Details |
| A11530 | 30855276 | J Clin Invest | A maresin 1/RORα/12-lipoxygenase autoregulatory circuit prevents inflammation and progression of nonalcoholic steatohepatitis. | 2019 | Details |
| A11531 | 30854954 | Curr Pharm Biotechnol | Combined Amelioration of Ginsenoside (Rg1, Rb1, and Rg3)-enriched Korean Red Ginseng and Probiotic Lactobacillus on Non-alcoholic Fatty Liver Disease. | 2019 | Details |
| A11532 | 30854694 | Aliment Pharmacol Ther | Relationship between resolution of non-alcoholic steatohepatitis and changes in lipoprotein sub-fractions: a post-hoc analysis of the PIVENS trial. | 2019 | Details |
| A11534 | 30854350 | Can J Gastroenterol Hepatol | Animal Models of Steatosis (NAFLD) and Steatohepatitis (NASH) Exhibit Hepatic Lobe-Specific Gelatinases Activity and Oxidative Stress. | 2019 | Details |
| A11535 | 30853445 | Transl Res | Role of the intestinal microbiome in liver fibrosis development and new treatment strategies. | 2019 | Details |
| A11536 | 30852481 | Pak J Pharm Sci | Clinical effect of the extract of TCM Fructus akebiae combined with ursodeoxycholic acid on nonalcoholic fatty liver disease. | 2019 | Details |
| A11538 | 30851741 | Lipids Health Dis | TRIB1 rs17321515 and rs2954029 gene polymorphisms increase the risk of non-alcoholic fatty liver disease in Chinese Han population. | 2019 | Details |
| A11539 | 30851372 | J Ethnopharmacol | Protective effect and mechanism of Qiwei Tiexie capsule on 3T3-L1 adipocytes cells and rats with nonalcoholic fatty liver disease by regulating LXRα, PPARγ, and NF-κB-iNOS-NO signaling pathways. | 2019 | Details |
| A11540 | 30851216 | Liver Int | Evaluating the association of serum ferritin and hepatic iron with disease severity in non-alcoholic fatty liver disease. | 2019 | Details |
| A11541 | 30851175 | J Gastrointestin Liver Dis | Short sleep duration is a risk of incident nonalcoholic fatty liver disease: a population-based longitudinal study. | 2019 | Details |
| A11542 | 30850637 | Sci Rep | Connectivity mapping of angiotensin-PPAR interactions involved in the amelioration of non-alcoholic steatohepatitis by Telmisartan. | 2019 | Details |
| A11543 | 30850619 | Sci Rep | Voluntary exercise in mice fed an obesogenic diet alters the hepatic immune phenotype and improves metabolic parameters - an animal model of life style intervention in NAFLD. | 2019 | Details |
| A11544 | 30850262 | Trends Endocrinol Metab | Calcium Signaling As a Therapeutic Target for Liver Steatosis. | 2019 | Details |
| A11545 | 30849993 | J Biomed Sci | Molecular functions and clinical impact of thyroid hormone-triggered autophagy in liver-related diseases. | 2019 | Details |
| A11546 | 30849452 | Toxicon | Nonalcoholic fatty liver disease alters microcystin-LR toxicokinetics and acute toxicity. | 2019 | Details |
| A11547 | 30849036 | Cleve Clin J Med | Assessing liver fibrosis without biopsy in patients with HCV or NAFLD. | 2019 | Details |
| A11548 | 30848932 | FASEB J | Berberine alleviates nonalcoholic fatty liver induced by a high-fat diet in mice by activating SIRT3. | 2019 | Details |
| A11549 | 30848827 | J Clin Endocrinol Metab | Plasma Fibroblast Growth Factor 21 Is Associated With Severity of Nonalcoholic Steatohepatitis in Patients With Obesity and Type 2 Diabetes. | 2019 | Details |
| A11550 | 30847862 | J Endocrinol Invest | Vitamin D status and non-alcoholic fatty liver disease in patients with type 1 diabetes. | 2019 | Details |
| A11551 | 30847736 | Curr Obes Rep | Changes in Bile Acid Metabolism, Transport, and Signaling as Central Drivers for Metabolic Improvements After Bariatric Surgery. | 2019 | Details |
| A11553 | 30844893 | Curr Opin Gastroenterol | Current treatment options for nonalcoholic fatty liver disease. | 2019 | Details |
| A11554 | 30842500 | Sci Rep | Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11555 | 30842494 | Sci Rep | Systems Genetics of Hepatic Metabolome Reveals Octopamine as a Target for Non-Alcoholic Fatty Liver Disease Treatment. | 2019 | Details |
| A11556 | 30841536 | Int J Mol Sci | mTOR is a Key Protein Involved in the Metabolic Effects of Simple Sugars. | 2019 | Details |
| A11557 | 30841472 | Biomed Pharmacother | Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis - Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogue. | 2019 | Details |
| A11558 | 30841442 | Biomed Pharmacother | Genistein can ameliorate hepatic inflammatory reaction in nonalcoholic steatohepatitis rats. | 2019 | Details |